CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $101,000 | +114.9% | 5,978 | +52.5% | 0.01% | +100.0% |
Q1 2020 | $47,000 | -60.8% | 3,919 | -60.3% | 0.00% | -40.0% |
Q4 2019 | $120,000 | +160.9% | 9,883 | +141.0% | 0.01% | +150.0% |
Q2 2019 | $46,000 | +142.1% | 4,100 | +156.2% | 0.00% | +100.0% |
Q1 2019 | $19,000 | -98.2% | 1,600 | -97.9% | 0.00% | -98.6% |
Q4 2018 | $1,035,000 | +30.0% | 77,506 | +36.5% | 0.07% | +50.0% |
Q3 2018 | $796,000 | -12.3% | 56,769 | -1.7% | 0.05% | -19.3% |
Q2 2018 | $908,000 | -2.8% | 57,769 | +1.8% | 0.06% | -16.2% |
Q1 2018 | $934,000 | -0.2% | 56,769 | +9.6% | 0.07% | -9.3% |
Q4 2017 | $936,000 | +50.0% | 51,801 | +60.1% | 0.08% | +33.9% |
Q3 2017 | $624,000 | +297.5% | 32,349 | +142.7% | 0.06% | +273.3% |
Q2 2017 | $157,000 | -18.2% | 13,329 | -24.0% | 0.02% | -16.7% |
Q1 2017 | $192,000 | -29.4% | 17,529 | -53.2% | 0.02% | -45.5% |
Q4 2016 | $272,000 | +361.0% | 37,429 | +214.5% | 0.03% | +266.7% |
Q4 2015 | $59,000 | +31.1% | 11,900 | 0.0% | 0.01% | +28.6% |
Q3 2015 | $45,000 | – | 11,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,951,077 | $178,226,000 | 9.95% |
Parallel Advisors, LLC | 3,769,455 | $96,649,000 | 4.45% |
Novo Holdings A/S | 3,327,768 | $85,324,000 | 4.07% |
TANAKA CAPITAL MANAGEMENT INC | 35,539 | $911,000 | 2.72% |
Quantedge Capital Pte Ltd | 243,712 | $6,249,000 | 1.93% |
S&T BANK/PA | 349,456 | $8,960,000 | 1.73% |
Birchview Capital, LP | 50,000 | $1,282,000 | 0.90% |
Bridge City Capital, LLC | 61,254 | $1,571,000 | 0.86% |
FAS Wealth Partners, Inc. | 299,576 | $7,681,000 | 0.85% |
AJ WEALTH STRATEGIES, LLC | 509,934 | $13,075,000 | 0.76% |